Niagen Bioscience, Inc. (NAGE) earnings
NAGE earnings moved a median of -3.68% by the close. Quarterly and annual NAGE reports and results, each read against the price at its own news timestamp. Back to the NAGE overview →
16 measured NAGE earnings events.
Where these NAGE earnings landedvs 16 measured NAGE earnings reactions
| Middle 50% of NAGE earnings reactions | -8.87% to +2.81% |
|---|---|
| Median reaction (to close) | -3.68% |
| Measured reactions | 16 |
Point-in-time · zero look-ahead
Half of the 16 NAGE earnings events with a measured close landed between -8.87% and +2.81%; 44% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Niagen Bioscience to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026 | Press release | +0.79% | +1.57% | |
| Form 10-Q Niagen Bioscience, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.65% | -4.52% | |
| Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results | Press release | +0.65% | -4.52% | |
| Niagen Bioscience to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026 | Press release | +2.10% | +4.80% | |
| Form 10-Q Niagen Bioscience, Inc. For: Mar 31 | SEC filing · Form 10-Q | -2.99% | -3.68% | |
| Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results | Press release | -2.99% | -3.68% | |
| Niagen Bioscience to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026 | Press release | -0.21% | +4.37% | |
| Form 10-K Niagen Bioscience, Inc. For: Dec 31 | SEC filing · Form 10-K | -5.97% | -10.37% | |
| Form 10-Q Niagen Bioscience, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.80% | -8.87% | |
| Niagen Bioscience, Inc. Reports Third Quarter 2025 Financial Results and Reaffirms Increased Full Year Outlook | Press release | -0.80% | -8.87% | |
| Niagen Bioscience to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 | Press release | +1.10% | +3.59% | |
| Form 10-Q Niagen Bioscience, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.16% | -14.20% | |
| Niagen Bioscience, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year Outlook | Press release | -1.16% | -14.20% | |
| Niagen Bioscience to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025 | Press release | -1.15% | +3.25% | |
| Niagen Bioscience, Inc. Reports First Quarter 2025 Financial Results and Increases Outlook | Press release | -1.67% | +2.67% | |
| Niagen Bioscience to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025 | Press release | +2.82% | +2.28% |
Keep exploring
More NAGE: analyst actions → · SEC filings → · NAGE overview →